Schumm, Philip External Author

Publications

Sort by

Selected publications

  • Phase I trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancerClinical Cancer Research2001 Academic Article GET IT
    Times cited: 123